JOIN THE BATTLE. Beat Rare Cancers.
Welcome to our team's page!
We are raising money for Cycle for Survival, the movement to beat rare cancers.
Will you help us surpass our fundraising goal?
In May of 2014, our mother, Sharon Fuller, was diagnosed with Lung cancer. In November of 2015, we learned the cancer had spread to her spinal fluid. Over the next year and a half (thanks to a clinical trial at Sloan Kettering for keeping her here that long) we watched our mother slowly disappear. She died in June of 2017. In April of 2017, our father, Doug Fuller, was diagnosed with Pancreatic cancer. In the month of August 2017, we learned it was no longer curable, as it had spread to his liver.
In September of 2017, our father died.
For us, this is extremely personal. It is painful and traumatic. Cancer showed up 3 and a half years ago, and continues to destroy our world, today. Please help us in the fight to beat cancer, so that other families never have to experience the pain and suffering we've been dealing with, and will deal with, for the rest of our lives.
Rare cancer research is underfunded, but we can change that. While we can’t all be doctors or researchers, we can raise the money that makes their lifesaving work possible. Cycle for Survival supporters have funded over one hundred clinical trials and studies, leading to new discoveries that are helping patients today.
But there is still more work to be done.
100% of every dollar you give funds pioneering research led by Memorial Sloan Kettering Cancer Center within six months of the events.
About 50% of all people diagnosed with cancer are battling a rare cancer. Too many people are touched by this disease, and yet many with rare cancers don’t have a proven, if any, treatment plan—that’s unacceptable.
Help us: Join our team or make a donation today. Your efforts will fight cancer and make a real impact.
Thank you in advance for your support! Together, we can bring new and better treatments to patients worldwide.
JOIN THE BATTLE. GIVE TODAY TO BEAT RARE CANCERS.
If you think this page contains objectionable content, please inform the system administrator